Home › NDC Lookup › RxCUI directory › RxCUI 197989

Mitoxantrone 2 MG/ML Injectable Solution — RxCUI 197989

RxNorm drug concept · Semantic clinical drug
RxCUI 197989 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 8 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI197989
Official nameMitoxantrone 2 MG/ML Injectable Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asmitoxantrone 20 MG per 10 ML Injectable Solution; mitoxantrone (as mitoxantrone hydrochloride) 2 MG/ML Injectable Solution; mitoxantrone 25 MG per 12.5 ML Injectable Solution; mitoxantrone 30 MG per 15 ML Injectable Solution; mitoxantrone 45 MG per 22.5 ML Injectable Solution
FDA products mapped4
Package NDCs mapped8
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Mitoxantrone Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats certain types of multiple sclerosis, where it reduces disability and relapses. It also treats pain from advanced hormone-refractory prostate cancer and, with other medici...
  • What is Mitoxantrone Injection used for?
  • A healthcare professional gives it through a vein. For MS, it is a short infusion about every 3 months. It must never go under the skin, into a muscle, or into the spinal fluid.
  • Nausea, hair thinning, menstrual changes, mouth sores and urinary tract infections are common. Your blood counts can also drop. Call your team for fever, signs of infection, shortn...
📖 Read our full Mitoxantrone Injection guide →

🕸️ Concept Web — How Mitoxantrone 2 MG/ML Injectable Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Mitoxantrone 2 MG/ML Injectable Solution RxCUI 197989

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Mitoxantrone 7005
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Mitoxantrone Injectable Solution 375173
    • Mitoxantrone Injectable Product 1165375
    • Injectable Solution 316949
    • Injectable Product 1151126
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Mitoxantrone 2 MG/ML 328493

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Mitoxantrone 2 MG/ML SCDC · 328493
  • Mitoxantrone Injectable Solution SCDF · 375173
  • Mitoxantrone Injectable Product SCDG · 1165375

📦 FDA Products & Package NDCs

4 products · 8 package NDCs
8 package NDCs map to RxCUI 197989 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
61703-0343-18 1 VIAL, MULTI-DOSE in 1 CARTON (61703-343-18) / 10 mL in 1... Mitoxantrone Hospira, Inc. 2006-04-11
61703-0343-65 1 VIAL, MULTI-DOSE in 1 CARTON (61703-343-65) / 12.5 mL in... Mitoxantrone Hospira, Inc. 2006-04-11
61703-0343-66 1 VIAL, MULTI-DOSE in 1 CARTON (61703-343-66) / 15 mL in 1... Mitoxantrone Hospira, Inc. 2006-04-11
63323-0132-10 1 VIAL, MULTI-DOSE in 1 BOX (63323-132-10) / 10 mL in 1 VIA... Mitoxantrone Fresenius Kabi USA, LLC 2006-04-11
63323-0132-12 1 VIAL, MULTI-DOSE in 1 BOX (63323-132-12) / 12.5 mL in 1 V... Mitoxantrone Fresenius Kabi USA, LLC 2006-04-11
63323-0132-15 1 VIAL, MULTI-DOSE in 1 BOX (63323-132-15) / 15 mL in 1 VIA... Mitoxantrone Fresenius Kabi USA, LLC 2006-04-11
71288-0178-10 1 VIAL, MULTI-DOSE in 1 CARTON (71288-178-10) / 10 mL in 1... mitoXANTRONE Meitheal Pharmaceuticals Inc. 2025-06-01
71288-0179-13 1 VIAL, MULTI-DOSE in 1 CARTON (71288-179-13) / 12.5 mL in... mitoXANTRONE Meitheal Pharmaceuticals Inc. 2025-06-01
Observed labelers: Fresenius Kabi USA, LLC (3) · Hospira, Inc. (3) · Meitheal Pharmaceuticals Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J9293 Mitoxantrone hydrochl / 5 mg 7 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.